Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Many guidelines and performance measures for chronic conditions, such as hypertension, seem to assume that patients come neatly packaged with only 1 problem. But patients’ conditions are often more complicated, and many patients have more than 1 condition. We know little about the impact that this multimorbidity has on care for common conditions like hypertension.
The Research Letter by Moise et al is novel because it clearly demonstrates that co-occurrence of depression has a significant impact on the treatment of hypertension. Specifically, patients who had a blood pressure higher than 140/90 mm Hg were less likely to have their hypertension medications intensified if they also had depression. Moise et al refer to this as clinical inertia. But is clinical inertia always bad? The answer is not clear.
Covinsky KE. Multimorbidity, Guidelines, and Clinical Inertia. JAMA Intern Med. 2014;174(5):819. doi:10.1001/jamainternmed.2013.14406